Skip to main content

Month: June 2022

Preliminary financial results for 05 month of 2022

In May, “Novaturas” group served 35 thousand customers, and the group’s revenue amounted to EUR 22 million. In total, during January-May, the company served 96 thousand customers, 3 times more than the same period last year. Cumulative January-May turnover reached EUR 67 million and is almost 4 times higher than the corresponding time in 2021.  “Growing revenues and customer flows show a consistent recovery of tourism sector. Despite the increase in fuel price, customers continue to demonstrate the need and desire for quality holidays in foreign resorts and entrust their vacation plans to our specialists”, says Vitalij Rakovski, head of “Novaturas” group.   The increasing numbers of travelers indicate this summer holiday season to be particularly active. This is also influenced by lifted travelling restrictions meant to manage the...

Continue reading

Fitch affirms Ageas’s AA- Insurer Financial Strength Rating with a Stable Outlook

   Fitch affirms Ageas’s AA- Insurer Financial Strength Rating with a Stable Outlook Fitch Ratings has affirmed ageas SA/NV’s Insurer Financial Strength (IFS) Rating at ‘AA-‘ (Very Strong). Fitch has also affirmed AG Insurance’s and Ageas Insurance Limited’s IFS Ratings at ‘AA-‘. All Rating Outlooks are Stable. The ratings reflect Ageas’ very strong business profile and capitalisation and its strong financial performance. Ageas is a listed international insurance Group with a heritage spanning almost 200 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow. As one of Europe’s larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global...

Continue reading

Reporting of Manager’s transactions – Deputy Chairman of the Board buys shares in TCM Group A/S

COMPANY ANNOUNCEMENT No. 145/2022 Tvis, 15 June 2022 Reporting of Manager’s transactions – Deputy Chairman of the Board buys shares in TCM Group A/S Pursuant to the Market Abuse Regulation article 19, TCM Group A/S (the “Company) hereby notifies receipt of information, that Deputy Chairman of the Board Anders Skole-Sørensen has bought shares in the Company for approx. DKK 0.2 million. Please see the attachment for details. For additional information, please contact:CEO, Torben Paulin, TCM Group, +45 21 21 04 64 About TCM GroupTCM Group is Scandinavia’s third largest manufacturer of kitchens and furniture for bathrooms and storage. The products are designed and produced in Denmark and rooted in a proud tradition of good quality and good craftsmanship. TCM Group pursues a multi-brand strategy, under which the main brand is Svane Køkkenet...

Continue reading

Changes in the Uponor Executive Committee

Andres Caballero Andres Caballero has been appointed President of Uponor’s Building Solutions – North America division and a member of the Executive CommitteeUponor Corporation, Stock exchange release, 15 June 2022 at 08:00 am EEST Changes in the Uponor Executive Committee Andres Caballero (M.Sc. Engineering, b. 1974) has been appointed President of the Building Solutions – North America division and a member of the Executive Committee at Uponor from 1 August 2022 at the latest. He will be based in Minnesota, USA and report to Michael Rauterkus, President and CEO, Uponor Corporation. Andres succeeds Bill Gray who stepped down from his role as President of Building Solutions – North America on 10 January 2022 to focus on interests outside the company. Current interim President of Building Solutions – North America, John Reutter...

Continue reading

WISeKey to Reverse Split its ADS on June 22, 2022

WISeKey to Reverse Split its ADS on June 22, 2022 Geneva, Switzerland, June 15, 2022 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules– WISeKey International Holding Ltd. (NASDAQ: WKEY / SIX: WIHN) (“WISeKey” or the “Company” or the “Group”), a leading cybersecurity and IoT company, announced today a 1-for-2 reverse split of American Depository Shares (“ADS”) listed on the NASDAQ under the ticker “WKEY.” Under the current ratio, 1 ADS represents 5 Class B common shares listed on the Swiss Stock Exchange which means that, post-split 1 ADS will represent 10 Class B common shares. The number of shares owned by ADS holders will be adjusted after the closing bell on Wednesday, June 22, 2022. There will be no change to the total number of the Company’s Class B common shares. The ADS holders of record on the effective date of the...

Continue reading

Press release Biocartis Group NV: Biocartis Reaches Key Commercial Milestones: One-Millionth Idylla™ Cartridge Sold and 2,000th Idylla™ Instrument Placed

PRESS RELEASE: 15 June 2022, 07:00 CEST Biocartis Reaches Key Commercial Milestones: One-MillionthIdylla™ Cartridge Sold and 2,000thIdylla™ Instrument Placed Mechelen, Belgium, 15 June 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces a double milestone today: the selling of its one-millionth commercial Idylla™ cartridge and the placement of its 2,000th Idylla™ instrument since its commercial launch. These events mark a key commercial milestone for Biocartis, which has been commercializing its rapid and easy-to-use decentralized Idylla™ molecular diagnostics platform in more than 70 countries across the world since 2015. Biocartis launched its first commercial products, the Idylla™ instrument and the Idylla™ BRAF Mutation Test (CE-IVD), in the European...

Continue reading

Clariant reports markedly stronger sales growth and EBITDA expansion in Q1 2022

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  First quarter 2022 sales from continuing operations increased by 30 % in local currency and 26 % in Swiss francs to CHF 1.262 billion – pricing contributed 16 % to the strong top–line growth Continuing operations EBITDA was up 27 % to CHF 220 million EBITDA margin increased to 17.4 % from 17.3 % in the first quarter of 2021 First quarter performance underlines the ability to achieve mid-term targets Outlook 2022: Strong local currency growth for the Group with the aim to improveyear-on-year Group EBITDA margin level in a challenging geopolitical environment“I’m proud to announce that Clariant had a strong start to 2022 despite the turbulent environment. In the first quarter, we successfully generated compelling revenue growth and clearly increased absolute EBITDA. The Group’s higher-value...

Continue reading

Grieg Seafood ASA: Capital Markets Day 2022

Short-term and long-term targets reaffirmed and sustainable growth platform beyond 2026 well established Grieg Seafood is hosting a Capital Markets Day outside Stavanger, Norway today 15 June 2022 under the headline “Farming the ocean for a better future”. Grieg Seafood has farmed salmon for almost three decades and the company is today one of the world’s leading salmon farmers. The Grieg Seafood operations are concentrated in Norway and Canada. The ocean has the potential to provide low impact food for generations to come and sustainable farming practices are the foundation of the company’s operations. Grieg Seafood today confirmed its growth ambitions with a target of annual harvest volume of 90 000 tonnes in 2022 and 120-135 000 tonnes in 2026 depending on successful utilization of current capacity, available expansion...

Continue reading

Active Health Foods, Inc. to Focus on Anti-Aging Business

Los Angeles, CA, June 14, 2022 (GLOBE NEWSWIRE) — Active Health Foods, Inc. (OTC: AHFD) announced today that it has discontinued the previously announced business plans in the Energy Food Bars, Cannabis, and in the Coinchamp.com crypto-currency businesses. Effective last week, in conjunction with the acquisition of Bioidentical Hormones Inc. www.bio-hormones.com (BIO) and its wholly owned subsidiary, Australian Menopause Centre www.menopausecentre.com.au (AMC), AHFD shall focus only on the Anti-Aging Medicine Industry. Mr. Glen Bonilla, the former controlling shareholder and CEO, and Mr. Gregory Manos, are no longer affiliated with the Company. AHFD will continue to operate and expand its skin care company, Etrnl Cosmetics, which has a unique chaga mushroom product for healthy skin. The Company will be making some significant...

Continue reading

VectivBio Announces Pricing of $30 Million Public Offering of Ordinary Shares

Combined Gross Proceeds from Public Offering and Private Sale Total $50 Million BASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the pricing of a follow-on public offering of 5,715,000 ordinary shares at a public offering price of $5.25 per share for aggregate gross proceeds of approximately $30 million, before deducting underwriting discounts and commissions and offering expenses. In addition, VectivBio has granted the underwriters a 30-day option to purchase up to an additional 857,250 ordinary shares at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about June 17, 2022, subject...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.